Lysophospholipids like lysophosphatidic acid (LPA) and sphingosine 1-phosphate have been intensively studied over the last several decades, and these studies have resulted in the identification of their G protein-coupled receptors (GPCR) and in the discoveries of new drugs targeting GPCRs. However, lysophosphatidylethanolamine (LPE) has not attracted much research attention. Recently, we found several interesting points regarding the action and signaling of LPE, that is, its cell-type dependence, structure specificity, and unique signaling. In particular, LPE signaling through LPA1 receptor (type 1 lysophosphatidic acid receptor) was found to be cell type dependent, and LPEs with different chain lengths induced different responses in different cells without LPA1 involvement. Here, we review recent findings and propose possible action modes of LPE GPCRs in different cells.
GPCRs for lysophospholipids
G protein-coupled receptors (GPCRs) are the largest superfamily of receptors for intercellular signaling in man [1] . Lysophospholipids, such as, lysophosphatidic acid (LPA) and sphingosine 1-phosphate (S1P), are deacylated lyso-type forms of phospholipids [2, 3] . LPA and S1P act as intercellular lipid mediators by activating their GPCRs, that is, LPA1-6 or S1P1-5 [1, 4, 5] . Signal transduction research on the GPCRs has resulted in the development of GPCR agonists and antagonists [6] . New drugs targeting GPCRs, such as, FTY-720 (Gilenya) and AM-095 have been developed or are in the process of development [7, 8] . However, other lyso-type lipids have received little research attention.
Lysophosphatidylethanolamine

(LPE) like other lysophospholipids, is produced by PLA2 from phosphatidylethanolamine [9, 10] , and is present in human serum at concentrations of several hundred ng/ml [11] . Initial studies on the actions of LPE conducted in the 1990s focused mainly on plants. LPE accelerates fruit color development production and retards the senescence of flowers, leaves, and harvested fruits [12] [13] [14] . In the housefly, LPE showed antifungal and antibacterial activities, [15] and in 2006, LPE was discovered to be a neurotrophic activator in cultured PC-12 mammalian cells [16] . Furthermore, LPE was found to cause reversible skeletal neuromuscular paralysis in the presence of snake neurotoxins [17] . However, the roles played by LPE on different cell types and the identities of its receptors have not been well studied.
GPCRs for LPE
Recently, it was proposed that GPCRs are involved in the actions of LPE. In 2007, LPE was reported to induce [Ca 2+ ]i increases, chemotactic migration, and cellular invasion by
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SK-OV3 and OVCAR-3 human ovarian cancer cells [18] . Although the actions of LPE were found to be mediated through GPCRs, the involvements of LPA specific GPCRs were excluded [18] . We reported the effects of LPE in MDA-MB-231 human breast cancer cells and PC-12 neuronal cells [1, 3, 19] , and unlike that reported in ovarian cancer cells, we found LPA1 was involved in LPE signaling [1, 3, 19] . In this review, we compare LPE receptors in calcium signaling, structure-activity relationship, receptor desensitization, and involvement of LPA GPCR.
Comparison of LPE actions
Calcium signaling
Park et al. showed LPE-induced [Ca 2+ ]i in two human ovarian cancer cells, SK-OV3 and OVCAR-3, but not in A431, HCT-116, HeLa, MCF-7, and U937 cells [18] . In 2013, we demonstrated that LPE induced [Ca 2+ ]i in MDA-MB-231 human breast cancer cells, but not in MCF-7, SK-BR3, and T47D breast cancer cells [20] , and confirmed the same effect in PC-12 neuronal cells [21] . Thus, the effects of LPE on [Ca 2+ ]i response have been confirmed in three specific cell types, that is, SK-OV3 ovarian cancer, MDA-MB-231 breast cancer, and PC-12 neuronal cells.
LPE structure
Structure-activity relationships of LPE on [Ca 2+ ]i increases in MDA-MB-231 breast cancer, PC-12 neuronal cells, and SK-OV3 ovarian cancer were studied using structurally different LPEs, that is, oleoyl LPE (18:1 LPE), stearoyl LPE (18:0 LPE), octadecanyl LPE (ether-linked 18:0 LPE), palmitoyl LPE (16:0 LPE), and myristoyl LPE (14:0 LPE) [20, 21] . 18:1 LPE and 14:0 LPE elicited [Ca 2+ ]i responses, whereas 16:0 LPE did not, in all three cell types [20, 21] . Similarly, 18:1 LPE and ether-or ester-linked 18:0 LPE were found to induce [Ca 2+ ]i in SK-OV3 and PC-12 cells [20, 21] . However, ether-or ester-linked 18:0 LPE were not active in MDA-MB-231 cells [20] . These findings indicate SK-OV3 cells and PC-12 cells have similar structural preference for LPE responses, but that MDA-MB-231 cells differ [20, 21] . [20, 21] . However, in SK-OV3 cells, LPE pre-treatment did not affect [Ca 2+ ]i induction by LPA and LPA stimulation did not inhibit LPE-induced response [18] . These results suggest that LPE acts on LPA receptors in MDA-MB-231 and PC-12 cells, but not in SK-OV3 cells [18, 20, 21] .
Receptor desensitization
LPA1 involvement
To test whether LPE utilizes LPA receptors in MDA-MB-231, PC-12, and SK-OV3 cells, two structurally different antagonists of LPA1 and LPA3 receptors, that is, VPC32183 and Ki16425, and a specific LPA1 antagonist, AM-095, were applied. All three antagonists completely inhibited LPE-induced [Ca 2+ ]i response in MDA-MB-231 and PC-12 cells, [19] [20] [21] but did not affect LPE-induced [Ca 2+ ]i response in SK-OV3 cells [18, 20] . The involvement of LPA1 in [Ca 2+ ]i induction by LPE in MDA-MB-231 cells was further confirmed by LPA1 knock-down using LPA1 siRNA [20] . However, transfections with LPA1 siRNA did not interfere the LPE-induced [Ca 2+ ]i response in SK-OV3 cells [20] . These results indicate the effect of LPE on [Ca 2+ ]i response is mediated through LPA1 in MDA-MB-231 and PC-12 cells, but not in SK-OV3 cells [18] [19] [20] [21] .
Relations between LPE and GPCRs in different cell types
Several our studies on LPE and its receptors have indicated that LPE evokes [Ca 2+ ]i responses through GPCRs in some cell types, such as, SK-OV3, OVCAR-3, MDA-MB-231, and PC-12 cells [18] [19] [20] [21] . LPA1 involvement is cell-type specific, which is, it occurs in MDA-MB-231 and PC-12 cells but not in SK-OV3 cells. Furthermore, structure-activity relationships of LPE are similar in SK-OV3 and PC-12 cells, but differ in MDA-MB-231 cells [18] [19] [20] [21] , which suggests responses to LPE depend on cell type.
Cell type differences might be due to the presence of multiple GPCRs for LPE and/or the utilization of different combinations of GPCR heterodimers or oligomers. This suggestion is based on the observation that LPA1 induces specific responses in MDA-MB-231 and PC-12 cells, but not in other cell types, such as, MCF-7 and T47D cells, although these other types express LPA1 [20] . It is worth noting that LPA1 has never been reported to be responsive to any lysophospholipid other than LPA in LPA1-overexpressing cell systems [18] . Moreover, although SK-OV3 cells possess LPA1 receptor, it is evident the action mechanism of LPE in these cells involves a GPCR other than LPA1. Taken together, we propose a certain protein(s) might cooperate with LPA1 for LPE-induced calcium signaling in MDA-MB-231 and PC-12 cells, and that this protein is not expressed in SK-OV3 cells (Fig. 1) and unknown GPCR(s) for LPE are present in SK-OV3 cells (Fig. 1) .
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